
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.
Being AI-enabled is no longer enough. Learn how AI-native commercialization partners can help pharmaceutical companies orchestrate intelligence across markets, navigate Europe’s complex healthcare landscape, and create greater value through expertise, technology, and outcomes-based collaboration.






